Clinical Trials Browser

Spinocerebellar Degenerations × pembrolizumab × 1 year × Clear all

NCT04098068 2025-03-30

Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)

Phase 2 Completed

12 enrolled 12 charts

Spinocerebellar Degenerations